According to market observers, the grey market is expecting that Senores Pharmaceuticals IPO listing price would be around ₹676

Senores Pharmaceuticals shares are set to make their market debut on Monday after the allotment was finalised on December 26, 2024. Senores Pharmaceuticals IPO got a very strong response during its three-day bidding period from December 20 to December 24.

The stock ended at ₹562 on the NSE, down ₹38 or 6.33%, and at ₹557.80 on the BSE, down ₹35.90 or 6.05%. During the day, the stock touched a 52-week high of ₹609.65 and a low of ₹538.85. Despite the dip,

Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Senores Pharma IPO debuts Dec 30, oversubscribed 97.86x. Check listing price, GMP, and allotment now!

Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock witnessed some profit taking at higher levels.

Compare Senores Pharma and Ventive IPOs for potential listing gains. Discover which could deliver better returns!

The issue had opened for public subscription on December 20 to raise about ₹582 crore from the primary market.

The Rs 582.1-crore Senores Pharmaceuticals offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs 82.1 crore.

Senores Pharmaceuticals Ltd witnessed a stellar debut on stock exchanges, with shares surging nearly 43% against the issue price. The Ahmedabad-based company's IPO attracted substantial interest with 93.